Desmoplastic Small Round Cell TumorSymptoms, Doctors, Treatments, Advances & More
Learn About Desmoplastic Small Round Cell Tumor
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Cleveland Clinic Children's Outpatient Center
Peter Anderson is a Pediatrics provider practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 51 years. Dr. Anderson is rated as an Elite provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Osteosarcoma, Ewing Sarcoma, Desmoplastic Small Round Cell Tumor, and Adult Soft Tissue Sarcoma. Dr. Anderson is board certified in American Board Of Internal Medicine, 1987.
Andrea Ferrari practices practicing medicine in Milan, Italy. Ms. Ferrari is rated as an Elite expert by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Rhabdomyosarcoma, Adult Soft Tissue Sarcoma, Desmoplastic Small Round Cell Tumor, Thyroidectomy, and Pancreatectomy.
Rockefeller Outpatient Pavilion
Mark Dickson is an Oncologist practicing medicine in New York, New York. Dr. Dickson is rated as an Elite provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Undifferentiated Pleomorphic Sarcoma, Synovial Sarcoma, and Endoscopy. Dr. Dickson is currently accepting new patients.
Summary: 3CAR is being done to investigate an immunotherapy for patients with solid tumors. It is a Phase I clinical trial evaluating the use of autologous T cells genetically engineered to express B7-H3-CARs for patients ≤ 21 years old, with relapsed/refractory B7-H3+ solid tumors. This study will evaluate the safety and maximum tolerated dose of B7-H3-CAR T cells.The purpose of this study is to find the ...
Summary: Patients participating in this study have DSRCT that has spread locally or to other parts of the body and can no longer be surgically removed without causing significant harm. Treatment will continue until the tumor progresses further, severe side effects occur, or either patient or investigator decision. In addition, patients may participate in an optional biological study. The study will analyze...